98%
921
2 minutes
20
Background: Patients treated in tertiary cardiac intensive care units (CICUs) often arrive via transfer from other hospitals. This "transfer population" is poorly described and has been largely excluded from trials in critical care.
Objectives: The aim of this study was to characterize patients who are transferred from other hospitals to advanced CICUs.
Methods: The Critical Care Cardiology Trials Network is an investigator-initiated network of predominantly North American CICUs. Consecutive CICU admissions during annual 2-month snapshots were submitted to the coordinating center (TIMI Study Group) and stratified by transfer vs nontransfer status. Adjustment was made for age, sex, study site, and Sequential Organ Failure Assessment score.
Results: A total of 21,215 admissions (2017-2023) were included in the analysis. Transfers accounted for 38% of admissions and 42% of patient-CICU-days. The primary reason for admission was more likely to be acute coronary syndrome (36% vs 15% for nontransfers, P < 0.001). Transfers were more likely to have shock (35% vs 32%, P = 0.031) and to receive mechanical ventilation (26% vs 17%, P < 0.001), renal replacement therapy (8% vs 5%, P < 0.001), and invasive monitoring (42% vs 34%, P < 0.001). Transfers with shock more frequently received mechanical circulatory support (15% vs 8%, P < 0.001). In-hospital mortality was higher among transfers, accounting for 44% of all deaths (15% vs 11%, P < 0.001; adjusted OR: 1.15 [1.04-1.27]).
Conclusions: Transfers account for more than 1 of 3 admissions to tertiary CICUs, require more complex care, and have higher mortality compared to nontransfers. These findings have implications for designing regional systems of care, hand-off communication, risk-adjusted reporting, and plans of care for this high-risk cohort.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacadv.2025.102046 | DOI Listing |
J Environ Pathol Toxicol Oncol
January 2025
Department of Pharmacy, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Despite advancements in systemic therapy, the mortality rate for patients with metastatic melanoma remains around 70%, underscoring the imperative for alternative treatment strategies. Through the establishment of a chemoresistant melanoma model and a subsequent drug investigation, we have identified pacritinib, a medication designed for treating myelofibrosis and severe thrombocytopenia, as a potential candidate to overcome resistance to melanoma therapy. Our research reveals that pacritinib, administered at clinically achievable concentrations, effectively targets dacarbazine-resistant melanoma cells by suppressing IRAK1 rather than JAK2.
View Article and Find Full Text PDFJ Neurosurg Case Lessons
September 2025
Department of Neurosurgery, St. Francis Hospital & Heart Center, Roslyn, New York.
Background: Myxoid spindle cell neoplasm and meningioma are two different pathologies that can have similar radiographic findings. Despite their benign radiographic appearance, myxoid spindle cell neoplasms are heterogeneous, prone to recurrence, and associated with high mortality.
Observations: The authors present the case of a woman in her late 60s who experienced a witnessed seizure characterized by right arm tonic-clonic movements and subsequent left-sided manifestations.
J Am Acad Orthop Surg
August 2025
From the Department of Orthopedic Surgery (Daher, Aoun, Sebaaly), Hotel Dieu de France Hospital, Beirut, LEBANON, the Department of Orthopedic Surgery (Daher, Diebo, Daniels), Brown University, Providence, RI, the Department of Orthopedic Surgery (Daher, Cottrill, Passias), Duke University, Durham,
Background: Surgical management of thoracolumbar fractures in patients with ankylosing spinal disorders such as ankylosing spondylitis (AS) and diffuse idiopathic skeletal hyperostosis remains debated. Although several studies have compared minimally invasive surgery to open fixation of thoracolumbar fractures in this patient population, a meta-analysis compiling the literature on this topic is lacking.
Methods: Following the PRISMA guidelines, PubMed, Cochrane, and Google Scholar (pages 1 to 20) were accessed and explored until October 2024.
Ann Am Thorac Soc
September 2025
University of Gothenburg Sahlgrenska Academy, Department of Internal Medicine and Clinical Nutrition, Gothenburg, Sweden.
Introduction: Co-morbid insomnia and sleep apnea (COMISA) has been linked to poorer health outcomes and increased all-cause mortality compared with either insomnia or obstructive sleep apnea (OSA) alone.
Materials And Methods: We investigated the relationship between COMISA and uncontrolled hypertension in the Swedish CardioPulmonary BioImage Study (SCAPIS). A cross-sectional analysis including participants from the SCAPIS Gothenburg cohort (n=3832, 46% males, age 57.
Crit Care Med
July 2025
Division of Critical Care, Department of Medicine, The Queen's Medical Center, Honolulu, HI.
Objectives: To evaluate the relationship between the duration of pre-extracorporeal membrane oxygenation (ECMO) mechanical ventilation and mortality in acute respiratory distress syndrome (ARDS) patients undergoing venovenous ECMO.
Design: Retrospective cross-sectional study using the National Inpatient Sample database.
Setting: National Inpatient Sample database from January 2019 to December 2022.